NFATc3 was found to impede HCC and hepatitis B virus replication by positively regulating RIG-I-mediated IFN transcription, illustrating that NFATc3 may exert an effect on the RIG-I pathway, which is vital for maintaining liver health and repressing viral replication (85). Here, RIGI is linked to hepatocellular carcinoma.